This is not the most recent version of the article. View current version (17 DEC 2013)

Intervention Protocol

Aripiprazole alone or in combination for acute mania

  1. Rachel Brown1,*,
  2. Matthew J Taylor2,
  3. Heather Wilder3,
  4. John Geddes4

Editorial Group: Cochrane Depression, Anxiety and Neurosis Group

Published Online: 26 JAN 2004

DOI: 10.1002/14651858.CD005000


How to Cite

Brown R, Taylor MJ, Wilder H, Geddes J. Aripiprazole alone or in combination for acute mania (Protocol). Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD005000. DOI: 10.1002/14651858.CD005000.

Author Information

  1. 1

    Oxfordshire & Buckinghamshire Mental Health Partnership NHS Trust, Clinical Pharmacy Support Unit, Oxford, UK

  2. 2

    University of Oxford, Department of Psychiatry, Oxford, Oxfordshire, UK

  3. 3

    Centre for Evidence Based Mental Health, Oxford, OXfordshire, UK

  4. 4

    University of Oxford/Warneford Hospital, Department of Psychiatry, Oxford, UK

*Rachel Brown, Clinical Pharmacy Support Unit, Oxfordshire & Buckinghamshire Mental Health Partnership NHS Trust, Unit 46, Sandford Lane, Kennington, Oxford, OX1 5RW, UK. Rachel.Brown@obmh.nhs.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 26 JAN 2004

SEARCH

This is not the most recent version of the article. View current version (17 DEC 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

1.To determine the efficacy of aripiprazole, either alone or in combination with other antimanic drug treatments, compared to placebo or other drug treatment in alleviating the acute symptoms of manic or mixed episodes.
2.To review acceptability of treatment with aripiprazole.
3. To investigate the adverse effects of aripiprazole treatment.
4.To determine overall mortality rates on aripiprazole treatment.